Aram V. Chobanian

Aram V. Chobanian's AcademicInfluence.com Rankings

Aram V. Chobanian

Philosophy

#6294

World Rank

#9306

Historical Rank

Logic

#3469

World Rank

#4631

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Aram V. Chobanian's Degrees

Doctorate Medicine Harvard University

Why Is Aram V. Chobanian Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Aram V. Chobanian's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (2003) (25415)
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (2003) (15453)
The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. (1988) (1028)
Physical activity and cardiovascular health. (1996) (913)
The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. (1984) (577)
Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. (2003) (513)
The heart in hypertension. (1992) (438)
Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. (1990) (434)
Shattuck Lecture. The hypertension paradox--more uncontrolled disease despite improved therapy. (2009) (375)
Triglyceride, high density lipoprotein, and coronary heart disease. (1993) (335)
National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : a critical review of current scientific evidence. (2000) (261)
Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. (1994) (241)
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. (1979) (214)
Growth factor expression in aorta of normotensive and hypertensive rats. (1989) (208)
Body cholesterol metabolism in man. I. The equilibration of serum and tissue cholesterol. (1962) (198)
Guidelines for the Management of Hypertension. (2017) (191)
High-normal blood pressure progression to hypertension in the Framingham Heart Study. (1991) (167)
Renal revascularization in the azotemic hypertensive patient resistant to therapy. (1984) (154)
Isoform-specific modulation of Na+, K+-ATPase alpha-subunit gene expression in hypertension. (1988) (152)
1989 Corcoran Lecture: Adaptive and Maladaptive Responses of the Arterial Wall to Hypertension (1990) (148)
The Metabolic and Hemodynamic Effects of Prolonged Bed Rest in Normal Subjects (1974) (131)
Exacerbation of atherosclerosis by hypertension. Potential mechanisms and clinical implications. (1996) (125)
Hypoaldosteronism; a clinical study of a patient with an isolated adrenal mineralocorticoid deficiency, resulting in hyperkalemia and Stokes-Adams attacks. (1957) (121)
The influence of hypertension and other hemodynamic factors in atherogenesis. (1983) (119)
Influence of Hypertension on Aortic Atherosclerosis in the Watanabe Rabbit (1989) (119)
Evaluation of the Hypertensive Patient with Emphasis on Detecting Curable Causes (1969) (115)
Effects of Hypertension and Its Reversal on Aortic Intima Lesions of the Rat (1980) (111)
Trandolapril inhibits atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. (1992) (109)
Isolated systolic hypertension in the elderly (2007) (106)
Control of hypertension--an important national priority. (2001) (101)
Aortic Endothelial and Subendothelial Cells in Experimental Hypertension and Aging (1981) (99)
Cholesteryl Ester Synthesis in Normal and Atherosclerotic Aortas of Rabbits and Rhesus Monkeys (1974) (97)
Effect of hypertension on fibronectin expression in the rat aorta. (1990) (93)
Apolipoprotein gene expression in the rabbit: abundance, size, and distribution of apolipoprotein mRNA species in different tissues. (1988) (92)
Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts. (1996) (91)
Effect of atherosclerosis on lysosomal cholesterol esterase activity in rabbit aorta. (1977) (88)
Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase. (1995) (87)
Regulation of intracellular calcium by cell pH in vascular smooth muscle cells. (1989) (81)
Effects of Propranolol on Atherogenesis in the Cholesterol‐Fed Rabbit (1985) (81)
The use of phospholipid vesicles for in vitro studies on cholesteryl ester hydrolysis. (1976) (78)
The in vivo transformation of phospholipid vesicles to a particle resembling HDL in the rat. (1976) (77)
Hypertension‐Induced Changes of Platelet‐Derived Growth Factor Receptor Expression in Rat Aorta and Heart (1991) (77)
THE ROLE OF DIURETICS IN THE MANAGEMENT OF HYPERTENSION (1960) (74)
CHLOROTHIAZIDE IN HYPERTENSION: STUDIES ON ITS MODE OF ACTION (1958) (69)
Pathophysiology of atherosclerosis. (1992) (68)
Comparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis. (1999) (67)
Body cholesterol metabolism in man. II. Measurement of the body cholesterol miscible pool and turnover rate. (1962) (66)
Effects of Hypertension and Its Reversal on Aortic Metabolism in the Rat (1978) (65)
Clinical practice. Isolated systolic hypertension in the elderly. (2007) (65)
Single Risk Factor Intervention May Be Inadequate to Inhibit Atherosclerosis Progression When Hypertension and Hypercholesterolemia Coexist (1991) (64)
Peptidyl dipeptidase in rabbit brain microvessels. (1978) (62)
Recent advances in molecular pathology. The effects of hypertension on the arterial wall. (1984) (62)
Adventitia as a source of inducible nitric oxide synthase in the rat aorta. (1999) (61)
Effects of Hypertension on Migration and Proliferation of Smooth Muscle in Culture (1985) (59)
Effects of Hypertension and Aging on Platelet‐Derived Growth Factor and Platelet‐Derived Growth Factor Receptor Expression in Rat Aorta and Heart (1991) (57)
Body fluid and electrolyte composition in arterial hypertension. II. Studies in mineralocorticoid hypertension. (1961) (57)
Body fluid and electrolyte composition in arterial hypertension. I. Studies in essential, renal and malignant hypertension. (1961) (56)
Hypertension induces alternatively spliced forms of fibronectin in rat aorta. (1992) (55)
The role of stress in hypertension. (1979) (53)
Angiotensin II alters aortic fibronectin independently of hypertension. (1994) (53)
Cardiovascular Complications (1982) (53)
Age-related changes in fibronectin expression in spontaneously hypertensive, Wistar-Kyoto, and Wistar rat hearts. (1992) (52)
Vascular effects of systemic hypertension. (1992) (49)
Effects of angiotensin II infusion and inhibition of nitric oxide synthase on the rat aorta. (1996) (49)
Relationship between diuretic and antihypertensive effects of chlorothiazide and mercurial diuretics. (1959) (48)
Properties and differential regulation of two fatty acid binding proteins in the rat kidney. (1988) (47)
Impact of nonadherence to antihypertensive therapy. (2009) (46)
Effect of nitric oxide on DNA replication induced by angiotensin II in rat cardiac fibroblasts. (1997) (45)
Effect of fish oil on atherogenesis in Watanabe heritable hyperlipidemic rabbit. (1990) (43)
Time to Reassess Blood-Pressure Goals. (2015) (43)
Metabolism of lipid in the human fatty streak lesion. (1972) (42)
Effects of Deoxycorticosterone‐Salt Hypertension on Cell Ploidy in the Rat Aorta (1986) (42)
Fibronectin biosynthesis in the rat aorta in vitro. Changes due to experimental hypertension. (1991) (41)
Prehypertension revisited. (2006) (41)
Does it matter how hypertension is controlled? (2008) (41)
Local myocardial blood flow as indicated by the disappearance of Nal-131 from the heart muscle: studies at rest, during exercise, and following nitrite administration. (1963) (39)
The effects of ACE inhibitors and other antihypertensive drugs on cardiovascular risk factors and atherogenesis (1990) (38)
Relationship of an abnormal plasma lipoprotein to protection from atherosclerosis in the cholesterol-fed diabetic rabbit. (1983) (38)
Properties of Angiotensin‐Converting Enzyme in Intact Cerebral Microvessels (1981) (37)
Smooth muscle cell migration and proliferation: atherogenic mechanisms in hypertension. (1987) (37)
Vascular changes in hypertension. (1987) (37)
Effects of endothelial denudation and cholesterol feeding on in vivo transport of albumin, glucose, and water across rabbit carotid artery. (1983) (37)
Converting enzyme inhibition in hypertensive emergencies. (1979) (36)
Cholesterol ester hydrolysis in aortic tissue. (1973) (36)
Phospholipid synthesis in the human arterial intima. (1966) (36)
Blood pressure lowering diminishes age-related changes in the rat aortic intima. (1984) (35)
Hypertension in 2017-What Is the Right Target? (2017) (35)
α1-Adrenergic Plus Angiotensin Receptor Blockade Reduces Atherosclerosis in Apolipoprotein E–Deficient Mice (1998) (34)
Antihypertensive therapy in evolution. (1986) (34)
Sterol synthesis in the human arterial intima. (1968) (31)
Use of propranolol in the treatment of idiopathic orthostatic hypotension. (1977) (31)
The effects of triparanol (MER-29) in subjects with and without coronary artery disease. (1960) (30)
Dissociation between the antiatherosclerotic effect of trandolapril and suppression of serum and aortic angiotensin-converting enzyme activity in the Watanabe heritable hyperlipidemic rabbit. (1995) (30)
Pathophysiologic considerations in the treatment of the elderly hypertensive patient. (1983) (29)
Alpha and beta adrenergic receptor activity in circulating blood cells of patients with idiopathic orthostatic hypotension and pheochromocytoma. (1982) (29)
Hypertension induces tissue-specific gene suppression of a fatty acid binding protein in rat aorta. (1988) (28)
Effects of head-down tilt on fluid and electrolyte balance. (1976) (28)
Calcium channel blockers. Lessons learned from MIDAS and other clinical trials. (1996) (27)
Effects of Hypertension and of Antihypertensive Therapy on Atherosclerosis State of the Art Lecture (1986) (26)
Studies on the activity of the sympathetic nervous system in essential hypertension. (1978) (26)
Response of the Aorta of the Obese Zucker Rat to Injury (1981) (26)
Biosynthesis of fibronectin by rabbit aorta. (1991) (24)
Effect of dietary cholesterol and alloxan-diabetes on tissue cholesterol and apolipoprotein E mRNA levels in the rabbit. (1991) (24)
Effect of angiotensin II blockade on the fibroproliferative response to phenylephrine in the rat heart. (1995) (23)
The arterial smooth muscle cell in systemic hypertension. (1987) (22)
A Comparative Study of the Effects of Oxprenolol Versus Propranolol in Essential Hypertension (1979) (21)
Improved hypertension control: cause for some celebration. (2010) (21)
Treatment of Chronic Orthostatic Hypotension with Ergotamine (1983) (20)
Role of the Peripheral Vasculature in Changes in Venous Return Caused by Isoproterenol , Norepinephrine , and Methoxamine in Anesthetized Dogs (2005) (20)
Hypertension and age: clinical and biochemical correlates. (1982) (20)
Mixed messages on blood pressure goals. (2011) (20)
Can antihypertensive drugs reduce atherosclerosis and its clinical complications? (1994) (19)
Effects of deoxycorticosterone/salt hypertension on cell ploidy in rat aortic smooth muscle cells. (1987) (19)
Overview: hypertension and atherosclerosis. (1988) (19)
Body Fluid and Electrolyte Composition in Cardiac Patients with Severe Heart Disease but without Peripheral Edema (1961) (19)
Angiotensin binding to rat adrenal capsular cell suspensions. (1973) (18)
Stress-induced proteins in aortic smooth muscle cells and aorta of hypertensive rats. (1990) (18)
Treatment of the elderly hypertensive patient. (1984) (18)
Effects of beta blockers and other antihypertensive drugs on cardiovascular risk. (1987) (18)
SPRINT Results in Older Patients: How Low to Go? (2016) (18)
Studies on the angiotensin II receptor in the zona glomerulosa of the rat adrenal gland. (1974) (18)
Effects of Calcium Channel Antagonists and Other Antihypertensive Drugs on Atherogenesis (1987) (17)
Selective induction of an embryonic fibronectin isoform in the rat aorta in vitro. (1993) (17)
Inhibition of Nuclear Polyploidy by Propranolol in Aortic Smooth Muscle Cells of Hypertensive Rats (1987) (16)
The metabolism of cholesterol esters in rat adrenal cell suspensions. (1973) (16)
Treatment of High Blood Pressure Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and (2012) (15)
The effect of cholesterol feeding on the metabolism of rabbit cerebral microvessels. (1979) (15)
Calcium Antagonists in Hypertension: Update 1986 (1987) (15)
Cholesteryl ester and triglyceride hydrolysis by an acid lipase from rabbit aorta. (1978) (15)
Effect of fasting on the composition of plasma lipoproteins in cholesterol-fed diabetic rabbits. (1985) (14)
Have long-term benefits of antihypertensive therapy been underestimated? Provocative findings from the Framingham Heart Study. (1996) (13)
Effects of sex hormones on phospholipid, RNA, and protein metabolism in the arterial intima. (1968) (13)
Relationship between Diuretic and Antihypertensive Effects of Chlorothiazide and Mercurial Diuretics (1959) (12)
Metabolism and Distribution of Intravenously Administered d‐Aldosterone‐l,2‐H3 in the Arteries, Kidneys, and Heart of Dog (1966) (11)
The antihypertensive actions of mercurial, thiazide, and spirolactone diuretics (1959) (11)
The effects of an inhibitor of cholesterol biosynthesis triparanol (MER-29), in subjects with and without coronary artery disease. (1959) (11)
TISSUE DISTRIBUTION OF CHOLESTEROL AND 24-DEHYDROCHOLESTEROL DURING CHRONIC TRIPARANOL THERAPY. (1965) (11)
Metabolism of sex hormones in the aortic wall. (1968) (11)
Alpha1-adrenergic plus angiotensin receptor blockade reduces atherosclerosis in apolipoprotein E-deficient mice. (1998) (11)
Effects of hypertension on arterial gene expression and atherosclerosis. (1991) (10)
Effects of hypertension and hyperlipidemia on the myocardium and coronary vasculature of the WHHL rabbit. (1992) (10)
Effects of lower body negative pressure on plasma catecholamine, plasma renin activity and the vectorcardiogram. (1974) (10)
Management of Patient Compliance in the Treatment of Hypertension: Report of the NHLBI Working Group (1982) (9)
The JNC 7 Hypertension Guidelines--Reply (2003) (9)
The Use of Angiotensin Converting Enzyme Inhibitors in Elderly Patients with Hypertension (1987) (9)
The Role of Angiotensin-Converting Enzyme Inhibitors in the Therapy of Cardiovascular Disease: An Overview (1989) (9)
Functional alteration of endothelium by short-term cholesterol feeding. (1986) (9)
The use of monoamine oxidase inhibitors as adjuncts in the treatment of hypertension and angina pectoris. (1960) (8)
Health care in Armenia today. (1994) (8)
Aortic Endothelial Changes During the Development and Reversal of Experimental Hypertension (1980) (7)
Arterial Lipid Metabolism in Diabetic Animal Models with Reduced or Elevated Plasma Insulin Levels (1974) (6)
COX-2 Inhibitors in Patients with Sensitivity to Nonselective NSAIDs (2009) (6)
Angiotensin converting enzyme inhibition in the therapy of cardiovascular diseases (1986) (6)
Evaluation, and Treatment of High Blood Pressure Seventh Report of the Joint National Committee on Prevention, Detection, (2008) (6)
Therapeutic decision-making in systolic hypertension. (1981) (6)
Relationship of basal plasma noradrenaline to blood pressure, age, sex, plasma renin activity and plasma volume in essential hypertension. (1978) (6)
The cholesterol lowering effects of triparanol (MER-29) in subjects with and without coronary artery disease. (1960) (6)
Aortic ornithine decarboxylase activity in deoxycorticosterone/salt hypertensive rats. (1991) (6)
Cholesterol metabolism in the diabetic Chinese hamster (1974) (5)
University of California, Davis, conference: Mild hypertension. (1988) (5)
Morphologic changes in the aorta of the diabetic Chinese hamster (1974) (5)
Inhibition of cholesterol-induced increases in arterial wall permeability by propranolol. (1987) (5)
Effect of endothelial cell denudation on fatty acid metabolism by rabbit aorta. (1990) (5)
Are Some Antihypertensive Therapies More Efficacious Than Others in Preventing Complications and Prolonging Life? (1991) (5)
The ASH special lecture comparison of the effects of ACE inhibition and AT1 receptor blockade on atherosclerosis (1998) (4)
Influence of hypertension and of antihypertensive drugs on the arterial wall. (1988) (4)
Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension. (1978) (4)
Comparison of Effects on Left Ventricular Filling Pressure of Intravenous Nesiritide and High-Dose Nitroglycerin in Patients With Decompensated Heart Failure (2004) (4)
Major improvements in the control of hypertension in Canada (2011) (4)
Potential Mechanisms and Clinical Implications (2015) (3)
Hypertension: Major risk factor for cardiovascular complications. (1976) (3)
Correction of enhanced endothelial permeability by cessation of cholesterol feeding. (1987) (3)
Critical Review of Current Scientific Evidence National Heart, Lung, and Blood Institute Workshop on Sodium and Blood Pressure : A (2013) (2)
Phospholipid methylation in rabbit aorta. (1986) (2)
Distribution and properties of angiotensin-converting enzyme in cerebral microvessels of the rabbit and rat. (1981) (2)
Effects of hypertension on hypercholesterolemia-induced changes in contraction of rabbit aorta and carotid artery. (1996) (2)
Editorial: Angiotensin inhibition. (1974) (2)
Hypertension, antihypertensive drugs, and atherogenesis. Mechanisms and clinical implications. (1986) (2)
The absence of a catechol estrogen effect on blood pressure in the male rat (1983) (2)
Acute pheochromocytoma. (1966) (2)
Fatty acyl CoA synthetase activity in normal and atherosclerotic rabbit aortic tissue. (1975) (2)
Celebration Improved Hypertension Control: Cause for Some (2010) (1)
Aortic glucose metabolism in the diabetic Chinese hamster (1974) (1)
Hypertension and coronary atherosclerosis (1989) (1)
Interaction between blood pressure, lipoproteins, angiotensin, and vascular disease (2002) (1)
Panel Discussion (Part II) (1988) (1)
Overview and Other Metabolic Issues and Concerns (1984) (1)
THEORETICAL SUBSTANTIATION OF THE MODEL OF PSYCHOLOGICAL SUPPORT OF SENIOR PRESCHOOLERS WITH INTELLECTUAL DEVELOPMENT DISORDERS (2020) (1)
The Influence of Atherosclerosis on Cholesterol Esterifying Activity of Rabbit and Monkey Aorta (1974) (1)
Saturday May 31, Ballroom A, 5:30 pm Calcium Antagonists in 1997: Emerging Perspectives and Future Directions: Antiatherogenic effects of calcium antagonists — Studies to date and future perspectives (1997) (0)
Use of surrogate or intermediate endpoints for assessing the effects of hypertension on atherosclerosis and its complications in man. (1997) (0)
The biochemistry of hypertension. National Academy of Clinical Biochemistry, 11th annual meeting. San Francisco, Calif. July 17-18, 1987. Proceedings. (1988) (0)
Overview and other metabolic issues and concerns in management of mild hypertension. (1984) (0)
Chobanian Celebration Improved Hypertension Control : Cause for Some Correction (2010) (0)
Treatment ofChronic Orthostatic Hypotension withErgotamine (1983) (0)
Role of calcium-channel blockers for treating hypertension in the 1990s. Roundtable discussion (1990) (0)
Effects of Trandolapril on Aortic Surface Atherosclerosis in Watanabe Heritable Hyperiipidemk Rabbits Aortic region Total aorta Ascending and arch Descending thoracic Abdominal Control (2005) (0)
CONTENT OF THE PROGRAM OF THE PROGRAM OF PSYCHOLOGICAL SUPPORT OF CHILDREN OF SENIOR PRESCHOOL AGE WITH DISABILITIES OF INTELLECTUAL DEVELOPMENT (2020) (0)
Book ReviewRenin and Hypertension: A modern synthesis. (1970) (0)
The use of beta-adrenergic blockers in hypertensive patients and their effects on the cardiovascular responses to exercise and stress (1990) (0)
BMQ : Boston medical quarterly: v. 10, no. 1-4 (1950) (0)
FORMATION OF SOCIAL READYNESS TO LEARN IN THE SCHOOL OF SENIOR PRESCHOOL CHILDREN WITH DISABILITIES OF INTELLECTUAL DEVELOPMENT BY MEANS OF PSYCHOLOGICAL SUPPORT PROGRAM (2020) (0)
Effects of ACE inhibitors on atherosclerosis in experimental animals (1995) (0)
What Have We Learned from Prior Clinical Trials of Antihypertensive Drug Therapy (1990) (0)
Arterial Responses to Hypertension (1991) (0)
Hypertension and Aging Induce Similar Changes in Molecular, Cellular, and Connective Tissue Responses of the Arterial Wall (1992) (0)
New guidelines for hypertension control in cardiac patients - lower may not be better. (2015) (0)
Pathophysiology of atherosclerosis. Discussion (1992) (0)
Evaluation of hypertensive patients. (1972) (0)
Heart Weight , Blood Pressure , and Heart Weight / Body Weight Ratio in Spontaneously Hypertensive and Normotensive Rats as a Function of Age Blood Heart Heart weight / pressure weight body weight (2005) (0)
Response (2019) (0)
Angiotensin Il-induced Cardiac Fibrosis in the Rat Is Increased by Chronic Inhibition of Nitric Oxide Synthase (0)
Fight or Flight: Adrenaline by Brian B. Hoffman (2013) Harvard University Press Cambridge, MA, USA (2013) (0)
WORKSHOP : PHARMACOLOGICAL AND NONPHARMACOLOGICAL THERAPIES IN HYPERTENSION (1991) (0)
Current Use of Diuretics in the Management of Hypertension (2016) (0)
The effect of hypertension and its reversal on the size and dna content of rat aortic smooth muscle cells (1985) (0)
Louis Tobian (1920–2006) (2006) (0)
Systolic Hypertension in the Elderly: A Therapeutic Problem (1982) (0)
Selected Papers on Lipid Metabolism (1970) (0)
Workshop Pharmacological and Nonpharmacological Therapies in Hypertension: Participants (1991) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Aram V. Chobanian?

Aram V. Chobanian is affiliated with the following schools: